The fiscal stability of the global gastrointestinal market is heavily influenced by the interplay between rising healthcare expenditures and government-mandated cost-containment measures. The Proton Pump Inhibitors Market Economic Outlook suggests a steady CAGR of 5.6%, with the global market valuation projected to reach nearly $6 billion by 2032. This growth is underpinned by the massive...

The global esomeprazole market is experiencing steady growth due to the increasing prevalence of gastrointestinal disorders and the growing demand for effective acid suppression therapies. Esomeprazole, a proton pump inhibitor (PPI), is widely prescribed for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and other acid-related...

The global gastrointestinal drugs market is witnessing strong growth due to the increasing prevalence of digestive disorders, rising healthcare awareness, expanding biologics development, and growing pharmaceutical innovations. Gastrointestinal drugs are widely used to treat disorders affecting the digestive tract, including irritable bowel syndrome (IBS), ulcerative colitis, Crohn’s...

According to a newly published market research report by 24LifeSciences, global Itopride Hydrochloride Tablets market was valued at USD 320 million in 2024 and is projected to reach USD 450 million by 2032, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025–2032. Itopride Hydrochloride, a gastrointestinal prokinetic agent that combines dopamine...